Thursday, August 03, 2017 11:35:35 AM
TransEnterix 2Q Loss/Shr 11c >TRXC
BY Dow Jones & Company, Inc.
— 4:05 PM ET 08/02/2017
TransEnterix, Inc. ( TRXC ) Reports Operating Results for the Second Quarter 2017 RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--August 02, 2017--
TransEnterix, Inc. ( TRXC ) , a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced its operating and financial results for the second quarter of 2017.
Recent Highlights
-- The Company sold a SenhanceTM Surgical Robotic System to Saitama Medical
University International Medical Center
-- The Company submitted its 510(k) application for the Senhance Surgical
Robotic System to FDA
-- The Company raised approximately $23.2 million through an equity
financing
-- The Company refinanced its debt, securing up to $17.0 million in debt
financing
-- In July, the Senhance platform was used in the first-ever robotic
micro-laparoscopic surgeries using 3mm instruments
-- In July, the Novadaq Pinpoint Fluorescence Imaging system was used in
conjunction with the Senhance platform
"We are very pleased with the progress we made during the quarter on our key strategic priorities, including the steps taken towards achieving 510(k) clearance for the Senhance by the end of 2017," said Todd M. Pope, President and Chief Executive Officer of TransEnterix ( TRXC
Loading...
Loading...
). "We are also encouraged by the continued momentum in clinical utilization in Europe, and now globally with our sale in Japan. In addition, we have been able to leverage the open architecture of the Senhance to incorporate cutting edge technologies into the platform, setting a new standard for minimally invasive robotic surgery."
Recent ASXC News
- Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024 • GlobeNewswire Inc. • 05/07/2024 10:55:00 AM
- Asensus Surgical Announces Sendai Tokushukai Hospital in Japan to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 04/29/2024 10:55:00 AM
- Asensus Surgical, Inc. Announces Non-Binding Acquisition Proposal and Exclusivity Arrangement with KARL STORZ SE & Co. KG • GlobeNewswire Inc. • 04/03/2024 12:45:00 PM
- Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter 2023 and Full Year 2023 • GlobeNewswire Inc. • 03/21/2024 08:05:00 PM
- U.S. Index Futures Rise as Fed’s Dovish Outlook Spurs Positive Investor Sentiment; Oil Prices See Minor Declines • IH Market News • 03/21/2024 11:26:38 AM
- Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024 • GlobeNewswire Inc. • 03/15/2024 10:55:00 AM
- Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference • GlobeNewswire Inc. • 02/28/2024 11:55:00 AM
- Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals • GlobeNewswire Inc. • 02/27/2024 11:55:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 12:01:47 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 12:00:04 AM
- Asensus Surgical Announces Nagoya University Hospital in Japan to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 01/16/2024 11:55:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 11:55:21 AM
- Asensus Surgical Provides Preliminary 2023 Year-End Corporate Update • GlobeNewswire Inc. • 01/08/2024 11:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 09:45:21 PM
- Asensus Surgical Completes In Vivo Surgeon Lab for LUNA Surgical Robotic System • GlobeNewswire Inc. • 01/04/2024 09:15:00 PM
- Asensus Surgical, Inc. to Present at the 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/03/2024 11:55:00 AM
- Asensus Announces Sale of Senhance Robotic System in Romania • GlobeNewswire Inc. • 12/20/2023 11:55:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/18/2023 11:26:08 PM
- Senhance Robotic System Sold by Asensus Surgical • GlobeNewswire Inc. • 12/04/2023 11:55:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:32 PM
- Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2023 • GlobeNewswire Inc. • 11/14/2023 09:05:00 PM
- Asensus Surgical Announces Sale of Senhance Robotic System • GlobeNewswire Inc. • 11/14/2023 11:55:00 AM
- Asensus Surgical, Inc. Announces Agreement with Flex for Design and Advanced Manufacturing Services for the LUNA™ Surgical System • GlobeNewswire Inc. • 11/13/2023 09:15:00 PM
- Asensus Surgical, Inc. Schedules Third Quarter Financial and Operating Results Conference Call for November 14, 2023 • GlobeNewswire Inc. • 11/07/2023 11:55:00 AM
- Asensus Surgical Announces Klinikum Idar-Oberstein Hospital in Germany to Initiate Senhance Surgery Program • GlobeNewswire Inc. • 11/06/2023 11:55:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM